iCoreConnect Inc. (NASDAQ:ICCT – Get Free Report) was the recipient of a large increase in short interest in the month of April. As of April 15th, there was short interest totalling 479,200 shares, an increase of 168.0% from the March 31st total of 178,800 shares. Based on an average daily volume of 406,900 shares, the short-interest ratio is presently 1.2 days. Currently, 5.8% of the company’s stock are short sold.
iCoreConnect Stock Down 2.1 %
Shares of NASDAQ ICCT opened at $1.08 on Friday. iCoreConnect has a 1-year low of $0.12 and a 1-year high of $20.70. The company has a fifty day moving average price of $1.31 and a 200 day moving average price of $1.46.
Hedge Funds Weigh In On iCoreConnect
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Destiny Wealth Partners LLC boosted its stake in iCoreConnect by 45.6% in the 4th quarter. Destiny Wealth Partners LLC now owns 101,675 shares of the company’s stock worth $132,000 after purchasing an additional 31,825 shares during the period. Sapient Capital LLC acquired a new position in shares of iCoreConnect during the 4th quarter worth about $39,000. Finally, Cowen AND Company LLC acquired a new position in shares of iCoreConnect during the 3rd quarter worth about $60,000. 13.42% of the stock is owned by institutional investors and hedge funds.
About iCoreConnect
iCoreConnect Inc, a cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company's products include iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, a solution that checks the patient's Prescription Drug Monitoring Program (PDMP) history before prescribing controlled substances; iCoreVerify and iCoreVerify+, a HIPAA compliant SaaS solution that automatically retrieves a patients insurance eligibility breakdown to verify their benefits in advance of their appointment and on-demand; iCoreHuddle and iCoreHuddle+, a tool to instantly reveal the revenue potential of each patient; and iCoreCodeGenius, a medical coding reference SaaS solution.
Read More
- Five stocks we like better than iCoreConnect
- How is Compound Interest Calculated?
- Hasbro’s Management Made All the Right Calls This Quarter
- Financial Services Stocks Investing
- Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower Prices
- Canadian Penny Stocks: Can They Make You Rich?
- Power Surge: Utilities Sector’s Resilience Shines
Receive News & Ratings for iCoreConnect Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iCoreConnect and related companies with MarketBeat.com's FREE daily email newsletter.